Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In …
F Nakhlis, BT Harrison, CS Giess, SC Lester… - Annals of surgical …, 2019 - Springer
Background A diagnosis of non-classic lobular carcinoma in situ (NC-LCIS) encompasses a
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In …
F Nakhlis, BT Harrison, CS Giess… - Annals of Surgical …, 2018 - europepmc.org
Background A diagnosis of non-classic lobular carcinoma in situ (NC-LCIS) encompasses a
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In …
F Nakhlis, BT Harrison, CS Giess… - Annals of Surgical …, 2019 - search.proquest.com
Background A diagnosis of non-classic lobular carcinoma in situ (NC-LCIS) encompasses a
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In …
F Nakhlis, BT Harrison, CS Giess, SC Lester… - Annals of Surgical …, 2019 - osti.gov
Background: A diagnosis of non-classic lobular carcinoma in situ (NC-LCIS) encompasses a
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
[PDF][PDF] Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular …
2018 - researchgate.net
Background. A diagnosis of non-classic lobular carcinoma in situ (NC-LCIS) encompasses a
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In …
F Nakhlis, BT Harrison, CS Giess, SC Lester… - Annals of Surgical …, 2019 - inis.iaea.org
Background A diagnosis of non-classic lobular carcinoma in situ (NC-LCIS) encompasses a
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In …
F Nakhlis, BT Harrison, CS Giess… - Annals of surgical …, 2019 - pubmed.ncbi.nlm.nih.gov
Background A diagnosis of non-classic lobular carcinoma in situ (NC-LCIS) encompasses a
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …
variety of lesions with poorly characterized natural history. We evaluated upgrade rates and …